oseltamivir has been researched along with clopidogrel in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzolari, A; Pedretti, A; Testa, B; Vistoli, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akhlaghi, F; Black, C; LeCluyse, EL; Shi, D; Yan, B; Yang, D; Yang, J; You, L | 1 |
| Shi, D; Song, X; Yan, B; Yang, D; Yang, J | 1 |
| Fowler, S; Hoffmann, G; Lennon, SM; Rayner, CR | 1 |
| Matsunami, N; Nagano, Y; Ono, H; Sugiyama, S; Tanabe, M; Yamamoto, S | 1 |
| Malmioja, K; Peura, L; Rautio, J | 1 |
| Antoku, Y; Hanatani, T; Hori, K; Kawakami, J; Kimura, M; Nakashima, N; Ohe, K; Sai, K; Saito, Y; Segawa, K; Tohkin, M; Yokoi, H | 1 |
| Merali, Z; Paré, G; Ross, S | 1 |
| Akhilesh, R; Chow, VTK; Malayer, JR; Maram, P; Pulavendran, S; Rudd, JM; Teluguakula, N; Thomas, PG | 1 |
| Markowitz, JS; Qian, Y | 1 |
4 review(s) available for oseltamivir and clopidogrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prodrug technology in the development of medicinal agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Delivery Systems; Drug Design; Humans; Lansoprazole; Oseltamivir; Prodrugs; Simvastatin; Ticlopidine | 2011 |
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Aspirin; Benzimidazoles; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Clopidogrel; Dabigatran; Factor Xa Inhibitors; Genotype; Humans; Imidazolidines; Irinotecan; Isoenzymes; Methylphenidate; Oseltamivir; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Pyridines; Ticlopidine | 2014 |
Natural Products as Modulators of CES1 Activity.
Topics: Administration, Intravenous; Administration, Oral; Biological Products; Carboxylic Ester Hydrolases; Clopidogrel; Drug Evaluation, Preclinical; Drug Interactions; Humans; Methylphenidate; Oseltamivir | 2020 |
7 other study(ies) available for oseltamivir and clopidogrel
| Article | Year |
|---|---|
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations.
Topics: Carboxylic Ester Hydrolases; Catalytic Domain; Computer Simulation; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Substrate Specificity | 2010 |
Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.
Topics: Antiviral Agents; Carboxylic Ester Hydrolases; Cell Line; Cell Survival; Clopidogrel; Drug Interactions; Humans; Hydrolysis; Mass Spectrometry; Microsomes; Mutagenesis, Site-Directed; Oseltamivir; Platelet Aggregation Inhibitors; Ticlopidine; Transfection | 2006 |
Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antiviral Agents; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Clopidogrel; Dose-Response Relationship, Drug; Female; Hepatocytes; Humans; Interleukin-6; Irinotecan; Liver Neoplasms; Male; Middle Aged; Oseltamivir; Platelet Aggregation Inhibitors; RNA, Messenger; Ticlopidine | 2007 |
Comments on "Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel".
Topics: Antiviral Agents; Biotransformation; Carboxylic Ester Hydrolases; Clopidogrel; Drug Interactions; Humans; Oseltamivir; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Area Under Curve; Body Temperature; Clopidogrel; Diclofenac; Dose-Response Relationship, Drug; Hypothermia; Male; Mice; Oseltamivir; Platelet Aggregation Inhibitors; Ticlopidine; Zanamivir | 2008 |
Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel.
Topics: Adolescent; Age Factors; Antiviral Agents; Child; Clopidogrel; Databases, Factual; Drug and Narcotic Control; Drug Interactions; Humans; Interrupted Time Series Analysis; Japan; Omeprazole; Oseltamivir; Pharmacovigilance; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proton Pump Inhibitors; Regression Analysis; Ticlopidine; Young Adult | 2014 |
Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.
Topics: Animals; Clopidogrel; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Extracellular Traps; Female; Histones; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Oseltamivir; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pneumonia, Viral; Thrombophilia; Virus Replication | 2019 |